Biobanking Market | Business Overview, Key Insights, Recent Developments
The Biobanking Market is expected to reach $2.69 billion, at a CAGR of 7.8%.
(IINews) - The Market Research Report on Biobanking, Considering useful aspects like; Application, Sample Type — Global Future Forecast, published by MarketsandMarkets™.
Factors driving the growth of this Biobanking Market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing need for cost-effective drug discovery and development.
The equipment segment is estimated to account for the largest share of the market. This is primarily attributed to the increasing number of biobanks and rising number of bio samples around the world, due to which the demand for equipment remains high.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594
The Biobanking Market report provides insights on the following pointers:
Biobanking Penetration: Comprehensive information on the product portfolios of the top players in the biobanking market
Biobanks Market Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the biobanks.
Biobanking Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the market
Biobanking Development: Comprehensive information about emerging markets. This report analyzes the market for various biobanking products across geographies
Biobanks Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the biobanking market
Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=594
Regenerative medicine applications for biobanking will drive the market
Biobanking Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the market.
Major Biobanking Market Developments
In 2017, Brooks Automation, Inc. (U.S.) launched BioStore IIIv, BioStudies Biobank Data Management, FluidX, IntelliXcap Decapper systems to strengthen its product portfolio in biobanking segment.
In 2016, Thermo Fisher Scientific Inc. (U.S.) entered into a partnership with Hamilton Storage (U.S.) to strengthened Thermo Fisher’s presence in the market.
In 2015, Panasonic Healthcare Holdings (Japan) launched MDF-DU900V VIP -86°C Upright Freezer.
Major Key Players Operating the Biobanking Market:
include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.).
Themen in diesem Fachartikel:
biobanking-market
biobanking
biobank
biobank-japan
lung-cancer
cancer-horoscope
biobanks-global-market
marketplace
uk-biobank
biobanking-market-by-product
biobanking-market
global-biobanking-industry-size
share
analysis-and-research-report
Unternehmensinformation / Kurzprofil:
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales(at)marketsandmarkets.com
Datum: 23.10.2019 - 11:12 Uhr
Sprache: Deutsch
News-ID 1764391
Anzahl Zeichen: 0
Kontakt-Informationen:
Ansprechpartner: shelly singh
Stadt:
northbook
Telefon: 18886006441
Kategorie:
Biotechnologie
Anmerkungen:
Dieser Fachartikel wurde bisher 188 mal aufgerufen.
Der Fachartikel mit dem Titel:
"Biobanking Market | Business Overview, Key Insights, Recent Developments
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).